Testicular Cancer Blood Screening
Tumour marker blood testing for testicular cancer assessment at our City of London clinic.
Testicular Cancer Blood Screening
All-inclusive price
- Blood draw by registered nurse
- Comprehensive lab analysis
- Detailed results report
- Detailed nurse-written review
- Follow-up recommendations
Or call 020 7183 3709
Pay at the clinic on the day of your appointment
About This Screening
Testicular Cancer Blood Screening
Testicular cancer is the most common malignancy in men aged 15 to 44, with approximately 2,300 new cases diagnosed annually in the UK. It has one of the highest cure rates of any cancer, exceeding 95% when identified at an early stage, making awareness and timely investigation clinically important.
This screening measures three established serum tumour markers associated with testicular germ cell tumours: Alpha-Fetoprotein (AFP), Beta-HCG (Human Chorionic Gonadotrophin), and Lactate Dehydrogenase (LDH). AFP is characteristically elevated in non-seminomatous germ cell tumours, while Beta-HCG may be elevated in both seminomas and non-seminomatous tumours. LDH is a less specific marker but may correlate with tumour burden.
Key Highlights
- Testicular malignancy has excellent prognosis when identified early
- Routine venepuncture with minimal discomfort
- Measures AFP, Beta-HCG, and LDH tumour markers
- Results typically available within 1 working day
- Baseline establishment for at-risk individuals
It is important to understand that tumour markers contribute to clinical assessment but are not diagnostic in isolation. Normal tumour marker levels do not exclude testicular malignancy, and mild elevations can occur in non-malignant conditions. Definitive assessment requires clinical examination and scrotal ultrasound alongside tumour marker measurement.
This screening is appropriate for men with established risk factors including a history of cryptorchidism (undescended testis), family history of testicular cancer, or previous contralateral testicular malignancy. It is also suitable for men who have noticed a testicular mass, swelling, or asymmetry, or those who wish to establish baseline tumour marker values. For men who have completed treatment for testicular cancer, regular tumour marker monitoring is an essential component of post-treatment surveillance, as directed by their oncology team.
The blood sample is collected by our registered nurse at our City of London clinic. All samples are processed by a UKAS-accredited laboratory. This screening provides laboratory data — it does not replace testicular self-examination or clinical assessment.
What's Included
Comprehensive testing covering all essential biomarkers for a complete health picture.
Tumour Markers
- Alpha-Fetoprotein
- Beta-HCG (Oncology)
- Lactate Dehydrogenase
Clinical Indications for Tumour Marker Assessment
Testicular cancer is the most common malignancy in men aged 15-44. Early-stage disease has excellent prognosis with cure rates exceeding 95%. This blood test measures three established tumour markers that may be elevated in testicular germ cell tumours.
Testicular malignancy has excellent prognosis when identified early
Routine venepuncture with minimal discomfort
Measures AFP, Beta-HCG, and LDH tumour markers
Results typically available within 1 working day
Baseline establishment for at-risk individuals
Appropriate for post-treatment surveillance
Who Should Take This Test?
Men Aged 15-44
Testicular cancer predominantly affects younger men. Those in this age group with risk factors should consider periodic assessment.
Established Risk Factors
Men with history of cryptorchidism (undescended testis), family history of testicular cancer, or previous contralateral malignancy have elevated risk.
Clinical Findings
Palpable testicular mass, swelling, or asymmetry warrants tumour marker assessment alongside physical examination.
Post-Treatment Surveillance
Men who have completed treatment for testicular cancer require regular tumour marker monitoring as directed by their oncology team.
How to Prepare
Follow these steps before your appointment for the most accurate results.
No fasting or special dietary preparation is required.
Continue taking any prescribed medications as normal.
Inform our team if you have a history of testicular conditions or previous treatment.
Regular testicular self-examination is recommended alongside this blood screening.
Allow approximately 10 minutes for your appointment.
Ready to Take Control of Your Health?
Book your Testicular Cancer Blood Screening today and get comprehensive insights into your health. Results available in 1 working day.
Frequently Asked Questions
Explore More Screenings
You Might Also Be Interested In
Patient Reviews
We're preparing to welcome our first patients at St Paul's Medical & Dental. Patient reviews will be available once we open our doors in April 2026.
We look forward to providing exceptional dental and medical care to the City of London community.
Meet Our Medical Team
Our experienced medical team is fully qualified and registered with the GMC and NMC, delivering safe, high-quality care in line with the highest professional standards.
Because our patients deserve nothing less.
Registered. Regulated. Trusted.
At St Paul's Medical & Dental, we are in process of registering with the Care Quality Commission (CQC) and our clinicians are registered with the relevant UK regulatory bodies, including the GDC and GMC. Our dentists, dental nurses and medical professionals deliver care that meets the highest clinical, safety and ethical standards, because our patients deserve nothing less.
